Rein Therapeutics Expands Phase 2 RENEW Trial into United Kingdom

Go back to Rein Therapeutics Expands Phase 2 RENEW Trial into United Kingdom
(NASDAQ: RNTX) Delayed: 0.80 -0.02 (2.44%)
Previous Close $0.82    52 Week High
Open $0.80    52 Week Low
Day High $0.82    P/E N/A 
Day Low $0.80    EPS
Volume 9,234